ELITE PHARMACEUTICALS INC /NV/ Annual Weighted Average Number of Shares Outstanding, Basic from 2011 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2011 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 1.07B shares, a 5.36% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.02B shares, a 0.25% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.01B shares, a 0.23% increase from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.01B shares, a 7.17% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 1.02B +2.53M +0.25% Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 1.01B +2.3M +0.23% Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 1.01B +67.6M +7.17% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2020 943M +111M +13.3% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-29
2019 832M +18.2M +2.23% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 814M +18.1M +2.27% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 796M -42.6M -5.08% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-21
2016 839M +165M +24.4% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-14
2015 674M +82.7M +14% Apr 1, 2015 Mar 31, 2016 10-K 2018-06-14
2014 591M +128M +27.7% Apr 1, 2014 Mar 31, 2015 10-K 2017-06-14
2013 463M +114M +32.6% Apr 1, 2013 Mar 31, 2014 10-K 2016-06-15
2012 349M +89.9M +34.7% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-30
2011 259M Apr 1, 2011 Mar 31, 2012 10-K 2013-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.